Search This Blog

Wednesday, August 7, 2019

Paratek Pharmaceuticals EPS beats by $0.14, beats on revenue

Paratek Pharmaceuticals (NASDAQ:PRTK): Q2 GAAP EPS of -$1.02 beats by $0.14.
Revenue of $2.05M (+5025.0% Y/Y) beats by $0.22M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)